Skip to content
DraconiticResearch
Search Sources API
210,043 studies31 sourcesUpdated 24 min ago

Oncology

5,302 studies557 in 7 days2,546 in 30 days

Filters
Type
Date
Clear

Latest

5,302 studies

  1. A Potent Solution for Tumor Growth and Angiogenesis Suppression via an ELR⁺CXCL-CXCR1/2 Pathway Inhibitor
    Oleksandr Grytsai, Maeva Dufies, Julie Le Du +9
    ACS Medicinal Chemistry LettersPeer-reviewedPublisher termsFull text3 citedOncologyPharmacology & toxicologyHAL
  2. Technical recommendations from a large-scale French Delphi consensus: A step toward European harmonization of ctDNA analysis
    Alexandre Harlé, Léa Payen, Alexandra Lespagnol +31
    European Journal of CancerPeer-reviewedCC BY 4.0Full text2 citedEpidemiology & public healthOncologyHAL
  3. Latent effector capacity governs reversible T cell exhaustion: A theoretical mathematical model of PD-1 blockade response
    Aubrey Y. Liew, Ying Li, Haidong Dong
    Science AdvancesPeer-reviewedCC BY-NCFull textOncologyCrossrefEurope PMC
  4. Fluke-borne viruses are a risk factor and diagnostic target for diseases caused by carcinogenic trematodes
    Sujittra Chaiyadet, Tom Roblin, Anais Fauchois +16
    Nature CommunicationsPeer-reviewedCC BY 4.0Full textOncologyCrossrefHAL
  5. Regimen selection for combined immunotherapy in non-small cell lung cancer with PD-L1 < 1%: a multicenter, retrospective study from Japan (SPIRAL-LT1)
    Daiki Murata, Koichi Azuma, Kenta Murotani +23
    Scientific ReportsPeer-reviewedCC BY 4.0Full textOncologyCrossref
  6. Immune biomarkers of response and resistance to ipilimumab and nivolumab in metastatic castration-resistant prostate cancer
    Apostolia M. Tsimberidou, Christopher R. Cabanski, Alexandra Drakaki +15
    Science advancesPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  7. Case Report: Recurrent retroperitoneal dedifferentiated liposarcoma after surgery
    Deng Hu, Yao-dong Wang, Shi-chun Jiang +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  8. Membrane anatomy-guided robot-assisted partial nephrectomy: operational definition and association with warm ischemia time in a single-surgeon cohort
    Wenhao Chu, Songbai Yan, Mengying Liao +6
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  9. Targeting GPX4 and FSP1 to exploit ferroptotic vulnerability in Ewing sarcoma
    Mian T. Mhindu, Stacia L. Koppenhafer, Mason G. Lyons +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  10. Artificial intelligence in breast cancer research: a systematic review and bibliometric analysis of emerging trends and future directions
    Yathreb Bayan Mohamed, Hanaa ZainEldin, Shymaa G. Eladl +4
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  11. Stable disease after multimodal treatment of SMARCA4-deficient undifferentiated tumor concurrently involving the stomach and mediastinum: a case report
    Jianbing Song, Yunzhi Xu, Jia Du +1
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  12. From inflammation to carcinogenesis: MiRNA regulates epithelial-mesenchymal transition to facilitate malignant progression of gastric precancerous lesions
    Yibing Tian, Tai Zhang, Bochao Yuan +3
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  13. Recent advances in targeted therapies and immunotherapies for triple-negative breast cancer
    Gowhar Rashid, Deena Elsori, Zainab Naqvi +7
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  14. FOXM1 as a candidate dosage rheostat and state selector in breast cancer: linking multilevel regulation to adaptive plasticity and therapy resistance
    Ghaleb Oriquat, Hani Moslem Ahmed, Jasur Rizaev +4
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  15. In-vitro cytotoxic and pro-apoptotic effects of an Echinococcus granulosus antigen B nanoformulation on CT26 colorectal cancer cells
    Soheil Sadr, Abbas Rahdar, Cinzia Santucciu +3
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  16. Clinical study of functional neuronavigation combined with intraoperative fluorescein sodium guided technique in the surgery of brain metastases
    Gai Hang, Weiran Yang, Zhong Wang
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  17. FDX1 is associated with CALR abundance and JAK–STAT-related inflammatory signaling in myeloproliferative neoplasms
    Diyaer Abuduaini, Diernu Simayi, Mihelayi Maimaiti +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  18. IL-6R blockade with tocilizumab disrupts pericyte– and tumor cell–driven IL-6/STAT3 signaling, enhancing docetaxel efficacy in ER+ breast cancer
    Róża K. Przanowska, Jacky Gomez-Villa, Victoria J. Liu +5
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  19. Selinexor enhances temozolomide efficacy in glioblastoma through modulation of multiple resistance-associated mechanisms
    Beyza Ozturk, Asuman Celebi, Deniz Kilic +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  20. Advances in γδ T cell-mediated immune surveillance in cervical cancer
    Jinlei Wang, Xiujun Xu, Qiang Li
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  21. Leveraging deep learning for prognostic stratification of hepatocellular carcinoma using histopathological images
    Dengbin Wu, Jiaoyue Zhang, Mian Shi +4
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  22. Cystoscopic submucosal indocyanine green marking in robot-assisted radical nephroureterectomy: a multicenter cohort study
    Runyi Wang, Menghua Wu, Haozhou Wang +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  23. Case Report: Apparent progressive complete mismatch repair protein loss during platinum-based chemotherapy in metastatic rectal neuroendocrine tumour grade 2
    Yue Yang, Gao Li, Jinghui Wang +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  24. Multi-modal spatial glycomic analysis of lymphoid aggregates in prostate and pancreatic cancer tissues
    Kameisha V. Rashford, Caroline G. Kittrell, Lyndsay E. A. Young +13
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  25. Peri-interventional neutrophil extracellular traps and immune surveillance in hepatocellular carcinoma: mechanisms, biomarkers, and recurrence after liver resection or thermal ablation
    Hang Xu, Jiayang Yi, Wanwan Zhang +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC